Ky19382 Powder

ky19382 powder is a novel orally active small molecule activator of the Wnt/β-catenin signaling pathway. As a dual inhibitor of CXXC5-DVL interaction and GSK3β, it effectively activates the Wnt/β-catenin signaling pathway, showing great promise in regenerative medicine, particularly for hair loss treatment and skin damage repair. As a chemical analog of indirubin-3'-monoxime (I3O), KY19382 possesses the advantage of low cytotoxicity. Functionally, it not only induces hair follicle regeneration, prolongs hair shaft length in human hair follicle cultures, and promotes wound-induced follicular regeneration (WIHN) to promote hair growth, but also accelerates skin wound healing and skin regeneration by accelerating cell migration, enhancing collagen deposition, and increasing the expression of stem cell markers in tissues such as hair follicles and keratinocytes. Currently, KY19382 is mainly used for hair loss treatment and research on skin repair mechanisms, while its potential application value in diet-related metabolic diseases is also being explored.If you want to know more about it, just contact Xi'an Sonwu Biotech Co., Ltd.

Xi'an Sonwu Biotech Co., Ltd is a peptide raw material supplier with peptide technology at its core and an international market orientation. Sonwu is dedicated to the R&D, manufacturing, and worldwide distribution of bioactive peptide and polypeptide ingredients. Sonwu's products are widely applied in multiple fields, including muscle building, beauty and anti-aging, hair health, weight management, nootropics, and pharmaceutical raw materials.

Sonwu's products serve a global clientele, supporting both research and development as well as industrialization projects. Based on this, Sonwu have received a lot of feedback on Sonwu's products. Therefore, if you need ky19382, please contact Xi'an Sonwu.

Xi'an Sonwu not only provides large-scale production services but can also provide sample packages to customers first.

Xi'an Sonwu not only supplies high-quality ky19382, but can also customize products according to customer needs. In addition, Sonwu can provide customized packaging services, including repackaging products according to customer requirements.
1. Customized bottles(size, color, material, style)
2. Customized packaging(vacuum foil packaging, box, drum)
3. Customized label(paint film, matte film, optical mask)

The core mechanism of action of KY19382 is to activate the Wnt/β-catenin signaling pathway through dual inhibition, while simultaneously regulating related auxiliary signaling pathways, thereby exerting multifaceted physiological effects. Its specific mechanism has been validated through cell experiments, animal experiments, and molecular biology techniques.

First, KY19382 is a dual inhibitor of CXXC5-DVL and GSK3β, exhibiting a high inhibitory activity with an IC50 of 19 nM for CXXC5-DVL and 10 nM for GSK3β. CXXC5 protein is a negative regulator of the Wnt/β-catenin signaling pathway; its interaction with DVL (disorganized protein) inhibits the activation of this pathway. KY19382, by blocking the binding of these two proteins, relieves this negative regulation, thereby activating the Wnt/β-catenin signaling pathway.

Second, KY19382 further enhances the activation effect of the Wnt/β-catenin signaling pathway by inhibiting the activity of GSK3β. GSK3β is a key kinase in the Wnt signaling pathway. Its overactivation leads to the phosphorylation and degradation of β-catenin. KY19382's inhibition of GSK3β reduces β-catenin degradation, promotes its accumulation in the cell nucleus, and thereby regulates the expression of downstream genes related to cell proliferation, migration, and differentiation, such as Col1a1, α-SMA, and keratin 14.

Furthermore, KY19382 can indirectly regulate the VEGFA/VEGFR2 and NFκB signaling pathways by activating the Wnt/β-catenin signaling pathway, promoting vascular endothelial cell migration and lumen formation, and inducing fibroblast transdifferentiation into myofibroblasts, thus supporting wound healing and tissue regeneration. This multi-pathway synergistic regulatory mechanism endows KY19382 with pleiotropic physiological functions.

ky19382 powder exhibits numerous advantages in physiological regulation and disease intervention, and its high safety profile has been experimentally verified. Its core benefits are mainly reflected in three aspects:

First, it is highly efficient and highly targeted. KY19382's inhibitory activity against CXXC5-DVL and GSK3β is at the nanomolar level, enabling it to precisely target specific sites and efficiently activate the Wnt/β-catenin signaling pathway. Compared to traditional non-specific activators, its efficacy is higher, and it reduces interference with irrelevant signaling pathways, lowering the risk of off-target effects.

Second, it is orally active and convenient to use. KY19382's orally available characteristic greatly enhances its clinical application and ease of use, reducing the difficulty of administration and the burden of patient compliance, laying the foundation for subsequent clinical translation.

Third, it has good safety and low cytotoxicity. Related experimental studies have shown that KY19382, within its effective concentration range, did not exhibit significant cytotoxicity against keratinocytes, dermal fibroblasts, or fragile primary neural stem cells, maintaining a high cell viability rate. Compared to some similar inhibitors with cytotoxicity, its safety profile is superior, providing a guarantee for long-term use.

Furthermore, KY19382 also possesses pleiotropic advantages, promoting both wound healing and hair regeneration, and remaining effective even in pathological states such as diabetes. This broadens its applicability and makes it more valuable than single-function modulators.

Currently, research on the application of KY19382 mainly focuses on two major areas: wound healing and hair regeneration, while also showing potential value in metabolic disease research.

In the field of wound healing, KY19382 is primarily used for the intervention of chronic wounds in diabetic patients. Chronic wounds in diabetic patients (such as diabetic foot ulcers) are difficult to heal, and conventional treatments have limited effectiveness. KY19382, by activating the Wnt/β-catenin signaling pathway, promotes collagen deposition, re-epithelialization, and angiogenesis at the wound site, significantly accelerating wound closure.

In the field of hair regeneration, KY19382 can be used to treat hair loss. The Wnt/β-catenin signaling pathway is a key regulatory pathway for hair follicle regeneration and hair growth. By activating this pathway, KY19382 can increase the activity of alkaline phosphatase (ALP) and the expression of the proliferation marker PCNA in human dermal papillary cells (DP cells), inducing hair regeneration and even promoting wound-induced hair follicle regeneration (WIHN). In addition, KY19382 can restore the damaged hair regeneration ability of diabetic patients and improve the growth status of human hair follicles in a high-sugar environment, providing a new direction for the treatment of diabetes-related hair loss.

1. Xi'an Sonwu Biotech Co . Ltd has established a complete technology platform covering peptide molecular design, custom synthesis, precision purification, structural identification, and quality control. Strictly adhering to international quality management standards, the company ensures that its peptide raw materials meet the high-end raw material requirements of overseas customers in terms of purity, stability, and batch consistency.

2. Looking to the future, Sonwu will continue to deepen peptide technology innovation, expand Sonwu's global cooperation network, and strive to become a trusted long-term peptide raw material solution partner for international customers.

Besides guaranteeing the product, the most important thing is that customers receive the goods smoothly. So, Xi'an Sonwu offers a range of couriers to meet different needs.

While the oral activity of KY19382 offers convenience, its absorption efficiency may fluctuate due to the influence of the gastrointestinal environment after oral administration. It may also cause mild gastrointestinal irritation, although no significant gastrointestinal adverse reactions were observed in relevant experiments. Further investigation is needed to confirm the specific side effects.

KY19382 has not shown significant side effects and has a good safety profile. Further in-depth research is required to clarify its long-term safety and potential risks.

If you want to find an ky19382 powder supplier, contact Xi'an Sonwu. Click the email, and then you get high-quality ky19382.

Email: sales02@sonwu.com

Hot Tags: ky19382 powder, China ky19382 powder manufacturers, suppliers, factory, anti hair loss peptides, Kopyrrol Powder, Ptd Dbm Peptide, Acetyl Tetrapeptide 3 Powder, Acetyl Dipeptide 3 Aminohexanoate Powder